Medtronic has received approval from the U.S. Food and Drug Administration (FDA) for a potentially revolutionary device that monitors glucose levels and delivers insulin automatically. The MiniMed 670G works as an “artificial pancreas," because its sensors constantly monitor insulin levels within the body and inject the dose needed accordingly.

Aetna will be offering Apple devices, such as the Apple Watch and iPhones, to further develop its wellness programs for employees and using iOS applications to simplify the healthcare process for patient and provider.

A new treatment for Crohn’s disease was approved by the FDA this week, one that aims to serve as an alternative for patients who are intolerant of immunomodulators or corticosteroids.

A report from the Government Accountability Office (GAO) harshly criticized HHS’s guidance on privacy and security for health information, saying it fails to meet cybersecurity standards of other federal agencies and provides advice to covered entities that doesn’t help prevent future data breaches.

PeriGen, a fetal surveillance system developer, plans to make waves in the market with the acquisition of the WatchChild Fetal Monitoring System from Hill-Rom, a multi-billion dollar holdings company based in Batesville, Indiana.